Therefore, either CCRT or sequential chemotherapy and radiotherapy can be accepted as first-line treatment for stage I/II NK/T-cell lymphoma patients, provided that effective non-anthracycline regimens particularly those containing L-asparaginase are used. The gene discussed is ASPG; the disease is T-cell non-Hodgkin lymphoma.